IBOV 172,236.05 ▲ 2.22% IPC MEX 71,866.30 ▲ 0.66% MERVAL 2,848,945 — — USD/BRL5.58▲ 1.23% USD/MXN18.71▲ 0.95% USD/CLP976.53▲ 0.96% USD/COP3,292▲ 5.51% USD/PEN3.41▲ 0.02% USD/ARS1,545▼ 0.02% USD/UYU40.45▲ 0.35% USD/PYG6,450▲ 1.45% USD/BOB11.74▼ 0.59% USD/DOP60.45▲ 2.39% USD/CRC446.56▼ 0.38% USD/GTQ7.64▼ 0.05% USD/HNL26.89▲ 0.02% USD/NIO36.62▲ 2.53% USD/VES897.02▲ 0.07% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▲ 2.42% USD/TTD6.72▼ 0.03% EUR/BRL6.24▲ 1.72% BRENT 89.56 ▼ 3.25% WTI 84.49 ▼ 2.72% IRON ORE 161.91 — — COPPER 6.25 ▼ 1.17% GOLD 4,058 ▼ 1.37% SILVER 51.77 ▼ 1.51% SOY 1,186 ▲ 0.34% CORN 439.75 ▲ 0.11% WHEAT 586.00 ▼ 0.34% COFFEE 265.40 ▼ 3.00% SUGAR 18.02 ▼ 1.04% ORANGE JUICE 144.80 ▲ 4.66% COTTON 78.30 ▼ 0.61% COCOA 4,860 ▼ 2.88% BEEF 216.33 ▲ 1.06% CATTLE 328.83 ▲ 2.02% LITHIUM 61.35 ▲ 0.72% PETR4 44.68 ▼ 1.13% VALE3 65.20 ▼ 1.38% ITUB4 41.82 ▲ 0.24% BBDC4 14.65 ▼ 0.20% ABEV3 15.63 ▲ 0.13% BBAS3 17.09 ▲ 0.41% B3SA3 14.90 ▲ 0.34% WEGE3 51.64 ▲ 1.77% PRIO3 59.02 ▼ 0.62% SUZB3 54.72 ▲ 0.96% RENT3 30.43 ▼ 1.30% AZZA3 15.04 ▼ 0.53% CSAN3 2.74 ▼ 1.08% RAIZ4 24.40 ▼ 12.86% PCAR3 2.40 ▼ 1.23% GMAT3 3.87 ▲ 1.04% PSSA3 45.81 ▲ 0.35% CVCB3 0.86 ▼ 1.15% POSI3 3.06 ▲ 0.99% SLCE3 16.95 ▼ 2.02% NATU3 5.63 ▼ 1.40% BRKM5 3.03 ▲ 0.33% RANI3 8.46 ▼ 3.42% CSNA3 4.43 ▼ 1.34% IBOV 172,236.05 ▲ 2.22% IPC MEX 71,866.30 ▲ 0.66% MERVAL 2,848,945 — — USD/BRL 5.58 ▲ 1.23% USD/MXN 18.69 ▲ 0.87% USD/CLP 976.65 ▲ 0.97% USD/COP 3,288 ▲ 5.40% USD/PEN 3.41 ▲ 0.02% USD/ARS 1,545 ▼ 0.02% USD/UYU 40.45 ▲ 0.35% USD/PYG 6,450 ▲ 1.45% USD/BOB 11.74 ▼ 0.59% USD/DOP 60.45 ▲ 2.39% USD/CRC 446.56 ▼ 0.38% USD/GTQ 7.64 ▼ 0.05% USD/HNL 26.89 ▲ 0.02% USD/NIO 36.62 ▲ 2.53% USD/VES 897.02 ▲ 0.07% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 2.42% USD/TTD 6.72 ▲ 2.10% EUR/BRL 6.24 ▲ 1.72% BRENT 89.56 ▼ 3.25% WTI 84.49 ▼ 2.72% IRON ORE 161.91 — — COPPER 6.25 ▼ 1.17% GOLD 4,058 ▼ 1.37% SILVER 51.77 ▼ 1.51% SOY 1,186 ▲ 0.34% CORN 439.75 ▲ 0.11% WHEAT 586.00 ▼ 0.34% COFFEE 265.40 ▼ 3.00% SUGAR 18.02 ▼ 1.04% ORANGE JUICE 144.80 ▲ 4.66% COTTON 78.30 ▼ 0.61% COCOA 4,860 ▼ 2.88% BEEF 216.33 ▲ 1.06% CATTLE 328.83 ▲ 2.02% LITHIUM 61.35 ▲ 0.72% PETR4 44.68 ▼ 1.13% VALE3 65.20 ▼ 1.38% ITUB4 41.82 ▲ 0.24% BBDC4 14.65 ▼ 0.20% ABEV3 15.63 ▲ 0.13% BBAS3 17.09 ▲ 0.41% B3SA3 14.90 ▲ 0.34% WEGE3 51.64 ▲ 1.77% PRIO3 59.02 ▼ 0.62% SUZB3 54.72 ▲ 0.96% RENT3 30.43 ▼ 1.30% AZZA3 15.04 ▼ 0.53% CSAN3 2.74 ▼ 1.08% RAIZ4 24.40 ▼ 12.86% PCAR3 2.40 ▼ 1.23% GMAT3 3.87 ▲ 1.04% PSSA3 45.81 ▲ 0.35% CVCB3 0.86 ▼ 1.15% POSI3 3.06 ▲ 0.99% SLCE3 16.95 ▼ 2.02% NATU3 5.63 ▼ 1.40% BRKM5 3.03 ▲ 0.33% RANI3 8.46 ▼ 3.42% CSNA3 4.43 ▼ 1.34%
since 2009
Tuesday, November 10, 2026

Covid-19 Brazil

Brazil eyes July for full local production of Oxford/AstraZeneca vaccine

By · · 2 min read

RIO DE JANEIRO, BRAZIL – Brazil could begin full production of Oxford/AstraZeneca’s COVID-19 vaccine by July if regulators allow, an official at biomedical center Fiocruz said, moving up by 100 days the timeline to produce shots without imported ingredients.

Fiocruz in Rio de Janeiro, will produce the Oxford/AstraZeneca vaccine in Brazil.
Fiocruz in Rio de Janeiro, will produce the Oxford/AstraZeneca vaccine in Brazil.
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Fiocruz Vice President Marco Krieger told Reuters that, if health regulator ANVISA waives some controls, the biomedical institute could move up the September 30th target date for 100% local production of the shot by AstraZeneca and Oxford University.

“This would be important at a time when Brazil is facing vaccine shortages,” Krieger said in an interview on Friday.

Delays in getting supplies from India and China have slowed Fiocruz’s finishing line and Brazil’s vaccination program. Only 6% of Brazil’s adult population has had their first of two shots.

Federally funded Fiocruz, based in Rio de Janeiro, has delivered 4 million ready-made vaccines from India and is filling and finishing shots with active ingredients from China. Delivery of those doses, starting this week, is expected tototal 100.4 million by July. Fully local production of the vaccine is scheduled for September, when Fiocruz plans to start delivery of 110 million doses for Brazil’s immunization program.

Given the urgent need for vaccines in Brazil, which lost more than 12,000 lives to the pandemic last week alone, Krieger said he hoped Anvisa would help to shorten that timeline.

As the vaccine is already in use in Europe and elsewhere, Krieger said Fiocruz may be able to get Anvisa’s approval after the regulator supervises production of just one batch, rather than the customary three batches.

Along with the 4 million AstraZeneca doses, Brazil’s government has received 20.6 million doses of CoronaVac, made by China’s Sinovac Biotech Ltd and bottled by Sao Paulo’s Butantan Institute with active ingredients from China.

On Friday, Anvisa granted final approval for AstraZeneca’s vaccine. CoronaVac has been approved for emergency use.

 

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.